BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.00−0.08 (-7.84%)
Close on Nov 17, 2026Market cap $7.51MP/E –Yield –
BioVie ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$5.69M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$2.94M | – |
See a number that looks wrong?